Search Results - "Bisgaard, Line S"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1/M2 marker expression – implications for atherosclerosis research by Bisgaard, Line S., Mogensen, Christina K., Rosendahl, Alexander, Cucak, Helena, Nielsen, Lars Bo, Rasmussen, Salka E., Pedersen, Tanja X.

    Published in Scientific reports (13-10-2016)
    “…Macrophages are heterogeneous and can polarize into specific subsets, e.g. pro-inflammatory M1-like and re-modelling M2-like macrophages. To determine if…”
    Get full text
    Journal Article
  2. 2

    The apoM/S1P Complex—A Mediator in Kidney Biology and Disease? by Bisgaard, Line S., Christoffersen, Christina

    Published in Frontiers in medicine (14-10-2021)
    “…Kidney disease affects more than 10% of the population, can be both acute and chronic, and is linked to other diseases such as cardiovascular disease,…”
    Get full text
    Journal Article
  3. 3

    Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice by Bisgaard, Line S, Bosteen, Markus H, Fink, Lisbeth N, Sørensen, Charlotte M, Rosendahl, Alexander, Mogensen, Christina K, Rasmussen, Salka E, Rolin, Bidda, Nielsen, Lars B, Pedersen, Tanja X

    Published in PloS one (16-12-2016)
    “…Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated…”
    Get full text
    Journal Article
  4. 4

    Kidney derived apolipoprotein M and its role in acute kidney injury by Bisgaard, Line S, Christensen, Pernille M, Oh, Jeongah, Torta, Federico, Füchtbauer, Ernst-Martin, Nielsen, Lars Bo, Christoffersen, Christina

    Published in Frontiers in pharmacology (2024)
    “…Apolipoprotein M (apoM) is mainly expressed in liver and in proximal tubular epithelial cells in the kidney. In plasma, apoM associates with HDL particles via…”
    Get full text
    Journal Article
  5. 5

    Uremia does not affect neointima formation in mice by Aarup, Annemarie, Nielsen, Carsten H., Bisgaard, Line S., Bot, Ilze, El-Ali, Henrik H., Kjaer, Andreas, Nielsen, Lars B., Pedersen, Tanja X.

    Published in Scientific reports (26-07-2017)
    “…Atherosclerotic cardiovascular disease is a major complication of chronic kidney disease (CKD). CKD leads to uremia, which modulates the phenotype of aortic…”
    Get full text
    Journal Article
  6. 6

    Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology by Bisgaard, Line S, Christoffersen, Christina

    Published in Current opinion in lipidology (01-06-2019)
    “…In 2011, the crystal structure of apolipoprotein M (apoM) and its capacity to bind sphingosine-1-phosphate (S1P) was characterized. Since then, a variety of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Uremia increases QRS duration after β‐adrenergic stimulation in mice by Thomsen, Morten B., Nielsen, Morten S., Aarup, Annemarie, Bisgaard, Line S., Pedersen, Tanja X.

    Published in Physiological reports (01-07-2018)
    “…Chronic kidney disease (CKD) and uremia increase the risk of heart disease and sudden cardiac death. Coronary artery disease can only partly account for this…”
    Get full text
    Journal Article
  9. 9

    Effect of atrial natriuretic peptide on lipolysis in the mouse heart by Bartels, Emil D, Bisgaard, Line S, Christoffersen, Christina, Nielsen, Lars B

    Published in Cardiovascular endocrinology (01-09-2014)
    “…Overweight is associated with triglyceride accumulation in cardiomyocytes, which can cause cardiac dysfunction. It is also associated with reduced synthesis…”
    Get full text
    Journal Article